Arch. Pharm. Pharm. Med. Chem. 2002, 335, 411–421
Chemical Properties of N-Chlorotaurine Sodium 421
[14] J. M. Zgliczynski, T. Stelmaszynska, J. Domanski, W. Os-
compartment of a double chamber cell (each 0.437 cm) was
filled with 1 mL of a NCT-Na solution (6.0–9.0 × 10–3 M) in wa-
ter and the other with 1 mL of the 1 M buffer solution. After
10 min at 25.0 °C in the thermostatted cell holder the first scan
was made. It was used for the calculation of the [NCT] at t = 0.
Then the contents of both compartments were mixed and
scanned at appropriate times (max 60 min).The NCT concen-
trations in the resulting NCT/NDCT mixtures were calculated
as described above. Since the plots of 1/[NCT]i against ti were
linear for the different pH values, the disproportionation reac-
tion is of second order with slopes indicating the observed rate
constants (Table 1).
trowski, Biochim. Biophys. Acta 1971, 235, 419–425.
[15] A.C.Carr, C.L.Hawkins, S.R.Thomas, R.Stocker, B.Frei,
Free Radical Biology & Medicine 2000, 30, 526–536.
[16] M. P. Snyder, D. W. Margerum, Inorg. Chem. 1982, 21,
2545–2550.
[17] H. E. Avery, Basic Reaction Kinetics and Mechanisms,
The Macmillan Press Ltd., London, 1974, Chapter 2 and
3.
[18] D. S. Mahadevappa, S. Ananda, N. M. M. Gowda, K. S.
Rangappa, J. Chem. Soc. Perkin Trans. II 1985, 39–43.
Statistics
[19] Ch. J. Patton, S. R. Crouch, Anal. Chem. 1977, 49(3),
Student’s paired t test as well as one way analysis of variance
(ANOVA) and Dunnett’s Multiple Comparison test (Graphpad
Software Inc., CA, USA) were applied. P values < 0.05 were
considered significant.
464–469.
[20] W. Gottardi, V. Bock in Fourth conference on Progress in
Chemical Disinfection (Ed: G. Janauer), University of
Binghamton (N.Y.), 1988, p. 35–60.
[21] J. J. Kaminski, M. M. Huycke, S. H. Selk, N. Bodor, T.
References
Higuchi, J. Pharm. Sci. 1976, 65, 1737–1742.
[1] M.B.Grisham, M.M.Jefferson, D.F.Melton, E.L.Thomas,
[22] A. Albert, E. P. Serjeant, The determination of ionization
J. Biol. Chem. 1984, 259, 10404–10413.
constants Chapman and Hall Ltd, London, 1971, Chapter
8.
[2] E. L. Thomas, Infect. Immun. 1979, 23, 522–531.
[23] C. Cunningham, K. F. Tipton, H.B. Dixon, Biochem. J.
1998, 330 , 939–945.
[3] K. Fukuda, Y. Hirai, H. Yoshida, T. Nakijima, T. Usui, Clin.
Chem. 1982, 28, 1758–1761.
[24] M. Nagl, W. Gottardi, Hyg. Med. 1996, 21, 597–605.
[4] P.Soupart in Amino acid pools (Ed.:J.T.Holden), Elsevier,
Amsterdam, 1962, pp. 220–262.
[25] W. Gottardi, M. Hagleitner, M. Nagl, J. Pharm. Pharmacol.
2001, 53, 689–697.
[5] M. Nagl, M. Hess, K. Pfaller, P. Hengster, W. Gottardi, Anti-
microb. Agents Chemother. 2000, 44, 2507–2513.
[26] W. Gottardi, Zbl. Bakt. Hyg. I. Abt. Orig. B. 1976, 162, 384–
388.
[6] J. Marcinkiewicz, Immunol. Today 1997, 18, 577–580.
[27] M. Nagl, C. Lass-Floerl, A. Neher, A. R. Gunkel, W. Gotta-
[7] T. Stelmaszynska, J. M. Zgliczynski, Eur. J. Biochem.
1974, 45, 305–312.
rdi, J. Antimicrob. Chemother. 2001, 47, 871–874.
[28] M. Nagl, C. Larcher, W. Gottardi, Antiviral Res. 1998, 38,
[8] Y.Y. Lin, C. E. Wright, M. Zagorski, K. Nakanishi, Biochim.
Biophys. Acta 1988, 969, 242–248.
25–30.
[29] M. Nagl, B. Teuchner, E. Pöttinger, H. Ulmer, W. Gottardi,
[9] M. Nagl, W. Gottardi, Hyg. Med. 1992, 17, 431–439.
Ophthalmologica 2000, 214, 111–114.
[10] J. H. Fellman, J. Labelled Compd. Radiopharm. 1981, 18,
[30] M. Nagl, B. Miller, F. Daxecker, H. Ulmer, W. Gottardi, J.
Ocular Pharmacol. Ther. 1998, 14, 283–290.
765–768.
[11] J. M. Antelo, F. Arce, P. Calvo, J. Crugeiras, A. Rios, J.
Chem. Soc., Perkin Trans. 2000, 2, 2109–2114.
[31] M.Nagl, B.Pfausler, E.Schmutzhard, M.Fille, W.Gottardi,
Zent. bl. Bakteriol. 1998, 288, 217–223.
[12] A. M. Cantin, J. Clin. Investig. 1994, 93, 606–614.
[13] E. L. Thomas, M. B. Grisham, M. M. Jefferson, Methods
Enzymol. 1986, 132, 569–585.